prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
Published 7 months ago • 92 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
2:41
assessing the prognostic value of ngs-based mrd in adults with all undergoing sct
-
3:35
minimal residual disease (mrd) as a prognostic factor for acute myeloid leukemia (aml)
-
5:18
the value of mrd as a prognostic tool in myeloma
-
3:14
the prognostic value of mrd negativity
-
1:42
immune profiling & mrd negativity of ndmm treated with quadruplet induction autosct: milestone trial
-
3:23
molecular characteristics associated with increased risk of disease progression in smm
-
13:07
mass spectrometry - interpretation made easy!
-
6:24
indiko biochemistry analyzer demonstration
-
1:55
piccolo xpress with capillary tube
-
1:53
the prognostic role of mrd in al amyloidosis
-
3:03
prognostic importance of mrd: results of tourmaline-mm4 trial for ndmm
-
1:30
the prognostic value of patient-reported outcomes in mds
-
3:27
mrd negativity using deep sequencing is a major prognostic factor in myeloma
-
1:38
using mrd as an endpoint in clinical trials
-
0:45
difference between quality of life & patient-reported outcomes
-
4:51
the impact of idh mutated clones in npm1 aml
-
4:02
the diagnostic and prognostic value of mass spectrometry in multiple myeloma
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
2:57
genetic biomarkers of response to venetoclax in aml
-
18:24
prognostic value of evaluating mrd dynamics in multiple myeloma maintenance